Trial intelligence / Profile preview

Comparative Study of Postoperative Nausea and Vomiting in Three Anesthetic Regimens for Temporomandibular Joint Arthroscopy

2017-000098-35Phase 4Active

Sponsor
Hospital Universitario La Paz
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of propofol and sevoflurane in temporomandibular disorder (TMD) and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Hospital Universitario La Paz. Primary endpoints: Presence and intensity of postoperative nausea and vomiting at 2 hours, Presence and intensity of postoperative nausea and vomiting at 6 hours and 1 more. Started Jul 2017; status: active.

02

Drugs

propofolsevoflurane
03

Conditions

temporomandibular disorder (TMD)postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on 2017-000098-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000098-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call